Wilson A G, Brooke O G, Lloyd H J, Robinson B F
Br Med J. 1969 Nov 15;4(5680):399-401. doi: 10.1136/bmj.4.5680.399.
The effect on exercise tolerance of racemic propranolol has been assessed in eight angina pectoris patients and compared with that of dexpropranolol (the dextro isomer of propranolol), practolol (I.C.I. 50172), and saline. Dexpropranolol has the same local anaesthetic action as propranolol with negligible beta-adrenergic receptor blocking activity, while practolol is a cardio-selective beta-adrenergic blocking agent which does not have local anaesthetic activity.Saline and dexpropranolol had no significant effect on exercise time; racemic propranolol and practolol improved exercise tolerance in six subjects, the response to the two drugs being very similar in individual patients. It was concluded that the beneficial effect of propranolol in angina pectoris results from its action as a beta-adrenergic receptor blocking agent and is not due to its local anaesthetic, or quinidine-like, activity.
已对8例心绞痛患者评估了消旋普萘洛尔对运动耐量的影响,并将其与右旋普萘洛尔(普萘洛尔的右旋异构体)、醋氨心安(ICI 50172)和生理盐水进行了比较。右旋普萘洛尔具有与普萘洛尔相同的局部麻醉作用,而β-肾上腺素能受体阻断活性可忽略不计,而醋氨心安是一种心脏选择性β-肾上腺素能阻断剂,不具有局部麻醉活性。生理盐水和右旋普萘洛尔对运动时间无显著影响;消旋普萘洛尔和醋氨心安使6名受试者的运动耐量提高,个体患者对这两种药物的反应非常相似。得出的结论是,普萘洛尔在心绞痛中的有益作用源于其作为β-肾上腺素能受体阻断剂的作用,而非其局部麻醉或奎尼丁样活性。